Matt Angel, Ph.D.
Board Member
Tempest Therapeutics, Inc. (TPST)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matt Angel, Ph.D.
Matt Angel, Ph.D. is recorded as Board Member and CEO at Tempest Therapeutics, Inc. (TPST). Tempest Therapeutics, Inc. reported in an 8-K filed November 19, 2025 that Matt Angel, Ph.D. was appointed Class I director. Tempest Therapeutics, Inc. reported in an 8-K filed November 19, 2025 that Matt Angel, Ph.D. was appointed President and Chief Executive Officer.
“The Parties shall take all necessary action so that Matt Angel, Ph.D. is appointed as the President and Chief Executive Officer and a Class I director of Purchaser, effective immediately after the Closing”
“The Parties shall take all necessary action so that Matt Angel, Ph.D. is appointed as the President and Chief Executive Officer and a Class I director of Purchaser, effective immediately after the Closing”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-11-19–present
-
Current
2025-11-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tempest Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Julia C. Owens CEO, Chairman
- Louis J. Arcudi III CEO, CFO, Board Member
- Matt Angel CEO, Board Member
- Stephen R. Brady CEO
- Mike Raab Chairman, Board Member
- Stephen Brady Chairman
- Constance Ames CFO
- Jennifer Minai-Azary CFO
- Justin Trojanowski CFO, Chief Accounting Officer
- Tamara Joseph General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.